Summary. Ovarian steroid metabolism was investigated (i) during development in a normal inbred strain in which post-natal follicle growth has been described and (ii) the major metabolite formed at all ages while androstenedione was the major androgen. Between 7 and 21 days there was an overall increase in steroidogenic enzyme activity with a peak of 5\g=a\-reductasebetween 21 and 29 days. The major metabolite of progesterone around puberty was 5\g=a\-pregnane-3\g=a\-ol-20-one. A sharp increase in 20\ g=a\ \ x=r eq-\ hydroxysteroid dehydrogenase was observed after 38 days due, presumably, to the appearance of corpora lutea. Unlike the rat, androstanediol levels were low at all ages.
Introduction
Ovarian steroid metabolism during development in the rat has been studied in several laboratories by measuring the metabolites formed from exogenous tritiated progesterone (Eckstein et ai, 1976; Karakawa et al., 1976; Eckstein & Ravid, 1979; Uilenbroek et al., 1983; Cohen et al, 1984) . In contrast, few studies have been carried out to examine steroidogenesis in the mouse ovary although this animal offers distinct advantages in the study of ovarian development. These advantages include the post-natal formation of primordial follicles and the availability of strains with specific mutations which affect the reproductive system. Kraiem & Samuels (1974) have measured changes in the activity of some steroidogenic enzymes in the ovaries of 25-day-old animals after gonado¬ trophin treatment. In this study we have examined changes in the overall pattern of steroid metabolism in the mouse ovary during development using a mouse strain in which the pattern of post-natal follicular development is known (Halpin et al, 1986) . We have developed a combination of thin-layer chromatography (t.l.c.) and high-performance liquid chromatography (h.p.l.c.) which separates more than 25 different gonadal steroids and allows use of [3H] pregnenolone as substrate, one step earlier in the steroidogenic pathway than progesterone. In addition to studying the pattern of development in the normal animal we have examined steroidogenesis in the adult hypo¬ gonadal (hpg) mouse. The hypogonadal (hpg) mouse lacks hypothalamic GnRH and is grossly deficient in pituitary and serum gonadotrophins which leads to severe hypogonadism (Cattanach et al, 1977) . The ovaries are capable of developing preovulatory follicles and fertile ova on trans¬ plantation into normal animals and therefore behave normally under the appropriate hormone stimulus. The hpg female is therefore ideal for the study of gonadotrophin control of ovarian function and for the determination of which components of the normal steroidogenic pattern are gonadotrophin-dependent.
Materials and Methods

Animals
The mice used in this study were normal or hpg animals reared in the Department of Anatomy, Royal Veterinary College, London, from breeding stock provided by Dr H. M. Charlton, Department of Human Anatomy, Oxford. The animals were derived originally from F, hybrids of two inbred strains C3H/HeH and 101/H (Cattanach et al., 1977) . The day of birth was designated as Day 0 and animals were used for experiment when aged 7, 21, 29, 38 and 60 days, ages previously used for morphological studies in this strain (Halpin et al., 1986) .
Materials
The radioactive steroids [4,7-3H] pregnenolone, [l,2,6,7,-3H] Steroid extraction and separation
The medium was extracted twice with 10 volumes of ethyl acetate. The extracts were dried and partitioned into neutral and phenolic steroids as described by Hutchison et al. (1981) . Steroids were then separated by a combination of t.l.c. and h.p.l.c. (Table 1) .
Thin-layer chromatography. Initial separation of the neutral steroids was by t.l.c. in chloroform:ether (7:1 v/v) using plastic-backed silica gel plates (Whatman, Maidstone, Kent, U.K.). The chromatogram was divided into 6 zones on the basis of standard steroids observed under u.v. light and by visualizing standards in control lanes using 5% phosphomolybdic acid in ethanol. Zone 1 had the highest RF value while zone 6 represented the origin. Zones 1, 2 and 3 contained 5a-dihydroprogesterone, progesterone and androstenedione respectively. In most experiments these steroids were cut out and counted directly in a scintillation counter. In some cases progesterone was eluted and retained for h.p.l.c. as described below to determine whether 5a-androstane-3,I7-dione was present. Zone 4 (area of t.l.c. between androstenedione and testosterone) was eluted with methanol and the steroids separated by h.p.l.c. (see below). Zone 5 extended from testosterone to the origin. This area was eluted in methanol and applied to a second t.l.c. separation using chloroform:methanol (97:3 v/v). This chromatogram was divided into 7 zones of decreasing RF value by visualization of standard steroids. Zones 1, 2, 3, 6 and 7 contained 17a-hydroxyprogesterone, 20a-dihydroprogesterone, testosterone, 5a-pregnane-3a,17a-diol and triols and these areas were counted directly (the triols were not further separated). Zone 4 contained I7ct-hydroxypregnenolone, 5a-pregnane-3ß,17a-diol, 5-pregnene-3ß,20a-diol, 5a-pregnane-3a,20a-diol and 5a-pregnane-3ß,20a-diol. This area was eluted and the steroids were acetylated as described previously (O'Shaughnessy et al., 1981 ). After acetylation steroids were separated by t.l.c. in chloroform:ether (7:1 v/v). This system did not allow resolution of A5-pregnane-3ß,20a-diol, 5a-pregnene-3a,20a-diol and 5a-pregnene-3ß,20a-diol which were not separated further. Zone 5 contained 5a-androstane-3ß,17ß-diol, androstanediol and androstenediol and these were separated by h.p.l.c. as described below. The NaOH fraction was neutralized by 4N-HC1 and the phenolic steroids were extracted twice with 10 volumes of ethylacetate. The dried steroids were acetylated and were separated by t.l.c. using dichloromethane:ethyl acetate (99:1 v/v) (Milewich et al., 1977 Fig. 1 . Nine steroids were separated in this step, eluted in the order DHEA, isoandrosterone, DHT, 5a-pregnane-17a-ol-3,20-dione, androsterone, pregnenolone, 5ot-pregnane-20a-ol-3-one, allopregnanolone and 5a-pregnane-3a-ol-20-one.
To separate steroids in zone 5 of the second t. Significant steroidogenic activity was present at 7 days and by 21 days the levels of activity were similar to those of the adult although the incubation conditions were not designed to measure the maximum steroidogenic ability. The effect of age on each of the metabolites reported in Table 2 was significant (P < 0-05) as assessed by analysis of variance. At all ages examined progesterone was the major metabolite formed (Table 2) with androstenedione the major C19 steroid. Between 7 and 21 days there was a marked increase in the levels of progesterone, androstenedione, 5a-dihydroprogesterone, allopregnanolone and 5a-pregnane-3a-ol-20-one, suggesting an increase in activity of 3ß-hydroxysteroid dehydrogenase-isomerase (3ß-HSD), C17-C20 lyase and 5a-reductase. At 21 and 29 days, 5a-pregnane-3a-ol-20 one was the major metabolite of progesterone formed. Between 29 and 38 days there was an increase in C19 steroid production, a decrease in overall 5a-reduced steroids and a sharp increase in 20a-dihydroprogesterone. High 20a-hydroxysteroid dehydrogenase (20a-HSD) activity and relatively low 5a-reductase activity were also observed in the mature animal of 60 days. Amounts of androstanediol were low at all ages although a peak of pro¬ duction was observed at 38 days. Intermediates from the 5 pathway of androgen production were not formed to a significant extent, suggesting that this pathway is relatively unimportant in the mouse ovary.
In the experiments described above, using [3H] A4-Pregnene-20a-ol-3-one A4-Androstene-17ß-ol-3-one 5a-Pregnane-3a, 17a-diol A5-Pregnene-3ß, 17a,20a-triol (triol)2 5a-Pregnane-3a, 17a,20a-triol (triol)* 5a-Pregnane-3ß, 17a,20a-triol (triol)8 A5-Pregnene-3ß,17a-diol-20-one 5a-Pregnane-3ß, 17a-diol-20-one A5-Pregnene-3ß,20a-diolb 5a-Pregnane-3a,20a-diolb 5a-Pregnane-3ß,20a-diolb A5-Androstene-3ß-ol-20-one(DHEA) 5a-Androstane-3ß-ol-17-one 5a-Androstane-17ß-ol-3-one (DHT) 5a-Pregnane-17a-ol-3,20-dione 5a-Androstane-3a-ol-17-one A5-Pregnene-3ß-ol-20-one 5a-Pregnane-20a-ol-3-one 5a-Pregnane-3ß-ol-20-one 5a-Pregnane-3a-ol-20-one A4-Pregnene-3,20-dione 
Discussion
The results described in this report have been summarized in Fig. 2 to show the major pathways of steroid metabolism which occur in the mouse ovary. Our results indicate that pregnenolone is mainly metabolized through progesterone and that the A5-pathway of C19 steroid production does not operate. The major progestagens formed are progesterone, at all ages, 5a-pregnane-3a-ol-20-one in the immature animal between 21 and 29 days and 20a-dihydroprogesterone from 38 days. Androstenedione was the major C19 steroid at all ages. From these results it is clear that the pattern of ovarian metabolism in the mouse during development differs from that in the rat, particularly in the production of C19 steroids. In the rat, accumulation of androstenedione and testosterone is very low or non-detectable during development (Karakawa et al, 1976; Uilenbroek et al, 1983) , the major products being androsterone and androstanediol which show a peak of production around the first ovulation (Eckstein et al, 1970; Karakawa et al, 1976; Inaba et al, 1978; Suzuki et al, 1978; Uilenbroek et al, 1983) . There was a peak in 5a-reductase activity in the mouse ovary between 7 and 38 days judged by the accumulation of 5a-reduced C21 steroids. This was reflected, however, in only low levels of androstanediol which peaked between 29 and 38 days, the time at which ovulation can first be observed in this strain of mouse (Halpin et al, 1986 5a-pregnane-3ct-ol-20-one and 5a-pregnane-3a,17a-diol-20-one (Karakawa et al, 1976; Inaba et al, 1978) . High levels of 5a-pregnane-3-ol-20-one are formed in the mouse but it does not appear to act as a substrate for C17-C20 cleavage in this species.
In the rat 20a-HSD is present in high concentrations in the regressing corpus luteum (Pupkin et al, 1966; Lahav et al, 1977) . At 38 days of age corpora lutea are present in 50% of mice of the strain used in this study (Halpin et al, 1986) and this coincides with an increase in 20a-HSD activity which is sustained up to 60 days. It seems likely, therefore, that 20a-HSD activity in the mouse ovary is also associated primarily with the corpus luteum. The presence of low activity before 29 days suggests that this enzyme must also be present in other tissue compartments of the ovary as it is in the rat (Eckstein et al, 1977) .
At 7 days the ovaries of the mouse strain used in this study contain follicles at stages of develop¬ ment up to type 5a in which there are 3 layers of granulosa cells (Halpin et al, 1986) . Development of interstitial tissue has not been examined in this strain although Quattropani (1973) (Peters, 1969) . It seems likely, therefore, that the pregnenolone metabolism observed in the ovary at 7 days is due primarily to activity in the granulosa cells with low levels of C19 steroid production occurring in the developing theca. Significant aromatase activity is also present at 7 days and thus the necessary enzymes are present in the ovary at this stage to allow oestradiol synthesis from pregnenolone. By 21 and 29 days the ovaries are highly active in preg¬ nenolone metabolism producing progesterone, 5cc-reduced C21 steroids and androgens (Fig. 2) . This is associated with the development of antral follicles (type 7) at 21 days and preovulatory follicles at 29 days (Halpin et al, 1986) . Evidence is now accumulating that ovarian follicles are gonadotrophin sensitive during the first week of life (Purandare et al, 1976; Terada et al, 1984; Halpin et al, 1986) . This is associated with high plasma FSH concentrations in the mouse which then decline towards puberty (Halpin et al, 1986) . It is possible, therefore, that changes in ovarian enzyme amounts during this time may also relate to the changes in plasma gonadotrophins in addition to follicular development. No marked differences in aromatase activity were observed in this study although the techniques used were not designed to measure the overall capacity of the tissue. There was no indication in the present studies that 16-keto-oestrone or 17-epioestriol were formed as reported by Vinson et al (1963) .
The hpg mouse offers a unique opportunity to study the function of GnRH-dependent gonado¬ trophin synthesis and secretion in gonadal development. The hpg mouse at the age used in this study contains follicles up to stage 5b (fully grown oocyte with many granulosa cells but no follicu¬ lar fluid) with occasional type 6 follicles (scattered areas of follicular fluid present) (Halpin et al, 1986) . The pattern of pregnenolone metabolism was similar to that of 7-day animals demonstrating that 3ß-HSD, 5a-reductase, C17-C20 lyase and 17a-hydroxylase are present. It is likely that these steroidogenic enzymes are under gonadotrophin control in the normal animal although it is clear from this study that activity may be expressed in the absence of gonadotrophin stimulation.
The ovaries of hpg mice contain 17-ketosteroid reductase (indicated using [3H]androstenedione as substrate) although the activity per ovary is markedly reduced compared to that of normal mice at any age studied. In addition, it is clear that 20a-HSD and aromatase are present at only very low levels or are absent in the hpg ovary. It is possible that levels of these enzymes are normal in immature hpg animals and that activity subsequently declines. Whether gonadotrophins are required for initial expression of these enzymes will require further study but it is clear that gonado¬ trophin stimulation is required during development for normal expression of these enzymes. The results described here agree with the studies of Kraiem & Samuels (1974) who demonstrated that the activities of 20a-HSD and aromatase are increased by gonadotrophins in the 25-day mouse ovary. The lack of aromatase activity in the hpg mouse ovary probably contributes to the inability of these follicles to develop to the antral phase. The data from the hpg mouse also suggest, however, that follicles can develop to the end of the pre-antral stage in the absence of gonadotrophins or ovarian oestrogen stimulation. M.A.M. was supported by the British council. We thank Dr H. M. Charlton for providing breeding stock and adult hypogonadal mice for use in these studies.
